| D011135 |
Polysaccharides, Bacterial |
Polysaccharides found in bacteria and in capsules thereof. |
Bacterial Polysaccharides |
|
| D011354 |
Prodigiozan |
A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. |
Prodigiosan |
|
| D002751 |
Chlortetracycline |
A TETRACYCLINE with a 7-chloro substitution. |
Aureocyclin,Aureomycin,Aureomycine,Biomycin,Chlorotetracycline,Chlortetracycline Bisulfate,Chlortetracycline Hydrochloride,Chlortetracycline Monohydrochloride,Chlortetracycline Sulfate (1:1),Chlortetracycline Sulfate (2:1),Chlortetracycline, 4-Epimer,Chlortetracycline, Calcium Salt,4-Epimer Chlortetracycline,Bisulfate, Chlortetracycline,Calcium Salt Chlortetracycline,Chlortetracycline, 4 Epimer,Hydrochloride, Chlortetracycline,Monohydrochloride, Chlortetracycline,Salt Chlortetracycline, Calcium |
|
| D004353 |
Drug Evaluation, Preclinical |
Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. |
Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug |
|
| D004359 |
Drug Therapy, Combination |
Therapy with two or more separate preparations given for a combined effect. |
Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D001428 |
Bacterial Vaccines |
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. |
Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial |
|
| D012283 |
Rickettsia prowazekii |
A species of gram-negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice (TYPHUS, EPIDEMIC LOUSE-BORNE) as well as Brill's disease. |
|
|
| D013997 |
Time Factors |
Elements of limited time intervals, contributing to particular results or situations. |
Time Series,Factor, Time,Time Factor |
|
| D014438 |
Typhus, Epidemic Louse-Borne |
The classic form of typhus, caused by RICKETTSIA PROWAZEKII, which is transmitted from man to man by the louse Pediculus humanus corporis. This disease is characterized by the sudden onset of intense headache, malaise, and generalized myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances. |
Brill's Disease,Brill-Zinsser Disease,Typhus,Brill Disease,Epidemic Typhus,Jail Fever,Louse-Borne Typhus,Rickettsia prowazekii Infection,Brill Zinsser Disease,Brills Disease,Epidemic Louse-Borne Typhus,Fever, Jail,Infection, Rickettsia prowazekii,Louse Borne Typhus,Louse-Borne Typhus, Epidemic,Rickettsia prowazekii Infections,Typhus, Epidemic,Typhus, Epidemic Louse Borne,Typhus, Louse-Borne |
|